{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Gram Positive Cefoxitin Screen",
        "VITEK 2 Cefoxitin Screen (OXSF)"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K053097",
    "Predicate Device Reference 510(k) Number(s)": [
        "N50510/S113"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 14, 2005",
    "Summary Letter Received Date": "November 3, 2005",
    "Submission Date": "October 31, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility Devices"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "mecA-mediated resistance in staphylococci"
    ],
    "Specimen Type(s)": [
        "Isolated colonies"
    ],
    "Specimen Container(s)": [
        ""
    ],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Automated antimicrobial susceptibility testing",
        "Microdilution methodology"
    ],
    "Methodologies": [
        "Qualitative susceptibility testing",
        "Automated monitoring",
        "Doubling dilution technique"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Gram Positive Cefoxitin Screen for qualitative prediction of mecA-mediated resistance in staphylococci using automated antimicrobial susceptibility testing",
    "Indications for Use Summary": "Qualitative test to predict mecA-mediated resistance in staphylococci using VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems as a laboratory aid for in vitro susceptibility to antimicrobial agents",
    "fda_folder": "Microbiology"
}